Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jennifer Taylor-Cousar

Concepts (317)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
111
2025
1065
21.940
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
67
2025
317
14.330
 Why?
Quinolones
27
2025
123
8.790
 Why?
Aminophenols
41
2025
141
8.560
 Why?
Benzodioxoles
27
2025
102
5.790
 Why?
Chloride Channel Agonists
26
2025
73
4.990
 Why?
Sinusitis
11
2024
205
3.880
 Why?
Indoles
16
2025
379
3.000
 Why?
Rhinitis
9
2024
152
2.960
 Why?
Olfaction Disorders
7
2024
60
2.190
 Why?
Aminopyridines
6
2025
96
2.160
 Why?
Mutation
34
2024
3723
2.020
 Why?
Pyrazoles
14
2025
406
1.950
 Why?
Membrane Transport Modulators
3
2020
7
1.920
 Why?
Pongo pygmaeus
3
2024
7
1.890
 Why?
Drug Combinations
21
2025
328
1.830
 Why?
Pregnancy Complications
5
2024
489
1.770
 Why?
Pyrrolidines
10
2025
65
1.700
 Why?
Ape Diseases
3
2024
7
1.640
 Why?
Pyridines
12
2025
474
1.560
 Why?
Reproductive Health
9
2024
82
1.440
 Why?
Pregnancy Outcome
6
2024
381
1.360
 Why?
Azithromycin
7
2021
93
1.360
 Why?
Humans
120
2025
130305
1.240
 Why?
Parents
5
2024
1313
1.170
 Why?
Quality of Life
16
2024
2735
1.160
 Why?
Respiratory System Agents
2
2020
22
1.160
 Why?
Reproductive Techniques, Assisted
3
2025
34
1.140
 Why?
Pregnancy
18
2025
6301
1.090
 Why?
Adult
57
2025
35711
1.060
 Why?
Paranasal Sinuses
5
2024
74
1.020
 Why?
Sexual Health
5
2024
53
0.930
 Why?
Female
67
2025
68842
0.930
 Why?
Pseudomonas Infections
9
2024
218
0.920
 Why?
Anti-Bacterial Agents
12
2024
1712
0.910
 Why?
Drug Approval
3
2024
88
0.900
 Why?
Pregnancy Rate
3
2021
60
0.900
 Why?
Pongo
2
2021
6
0.870
 Why?
Chronic Disease
13
2024
1727
0.840
 Why?
Lung Transplantation
1
2024
282
0.760
 Why?
Diabetes Mellitus
2
2022
1005
0.730
 Why?
Prospective Studies
15
2024
7131
0.720
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
19
0.710
 Why?
Sweat
9
2025
47
0.680
 Why?
Male
53
2025
63748
0.670
 Why?
Compassionate Use Trials
1
2019
7
0.670
 Why?
Drug Monitoring
6
2020
194
0.660
 Why?
Treatment Outcome
20
2025
10341
0.660
 Why?
Lung
9
2023
3967
0.660
 Why?
Aerosols
1
2020
173
0.660
 Why?
Precision Medicine
2
2021
388
0.640
 Why?
Fertility
3
2025
163
0.630
 Why?
Sputum
5
2022
309
0.630
 Why?
Pseudomonas aeruginosa
9
2022
344
0.620
 Why?
Forced Expiratory Volume
11
2023
509
0.580
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
260
0.550
 Why?
Breast Feeding
2
2022
427
0.550
 Why?
Aldehyde Oxidoreductases
1
2017
29
0.550
 Why?
Rifampin
1
2017
83
0.530
 Why?
Biomedical Research
3
2024
658
0.520
 Why?
Pongo abelii
1
2016
2
0.520
 Why?
Child
22
2025
20961
0.510
 Why?
Chlorides
8
2025
138
0.500
 Why?
Glucose Tolerance Test
1
2016
357
0.490
 Why?
Glucose Intolerance
1
2016
142
0.480
 Why?
Sildenafil Citrate
2
2014
59
0.480
 Why?
Bronchiectasis
1
2016
112
0.460
 Why?
Tobramycin
5
2019
52
0.460
 Why?
Leukocyte Elastase
1
2014
77
0.460
 Why?
Infertility, Male
2
2025
62
0.450
 Why?
Prenatal Exposure Delayed Effects
1
2020
553
0.440
 Why?
Adolescent
23
2025
20374
0.440
 Why?
Surveys and Questionnaires
9
2025
5400
0.440
 Why?
Young Adult
20
2025
12404
0.430
 Why?
Smell
3
2024
132
0.430
 Why?
Genetic Therapy
3
2023
296
0.420
 Why?
Double-Blind Method
10
2025
1878
0.400
 Why?
Respiratory Function Tests
6
2025
598
0.400
 Why?
Quinolines
3
2025
149
0.390
 Why?
Lactation
3
2022
171
0.390
 Why?
Homozygote
4
2021
192
0.360
 Why?
Drug Interactions
4
2020
370
0.330
 Why?
International Cooperation
2
2020
174
0.330
 Why?
Hypoventilation
1
2009
10
0.320
 Why?
Respiratory Muscles
1
2009
32
0.320
 Why?
Genotype
7
2023
1839
0.320
 Why?
ABO Blood-Group System
1
2009
41
0.310
 Why?
Parenting
2
2023
293
0.300
 Why?
Tomography, X-Ray Computed
4
2022
2551
0.290
 Why?
Needs Assessment
2
2020
363
0.280
 Why?
Blood Glucose
2
2016
2100
0.280
 Why?
Clinical Trials as Topic
2
2022
1015
0.260
 Why?
Polymorphism, Genetic
1
2009
643
0.250
 Why?
Asthma
3
2024
2265
0.250
 Why?
Observational Studies as Topic
2
2024
109
0.240
 Why?
Animals
10
2024
35076
0.240
 Why?
Infant, Newborn
4
2024
5741
0.230
 Why?
United States
9
2025
14110
0.230
 Why?
Alleles
6
2023
848
0.220
 Why?
Minimal Clinically Important Difference
1
2023
14
0.220
 Why?
Fertility Preservation
1
2024
54
0.220
 Why?
Pregnancy, Unplanned
2
2023
37
0.220
 Why?
Orphan Drug Production
1
2023
6
0.220
 Why?
Patient Selection
2
2019
678
0.220
 Why?
C-Reactive Protein
2
2018
396
0.210
 Why?
Abortion, Spontaneous
1
2023
100
0.210
 Why?
Respiratory Tract Diseases
1
2024
151
0.210
 Why?
Middle Aged
16
2025
31322
0.210
 Why?
Biomarkers
5
2024
3923
0.200
 Why?
Ion Transport
2
2021
57
0.200
 Why?
Body Height
1
2023
192
0.200
 Why?
Neonatal Screening
1
2024
164
0.200
 Why?
Puberty
1
2023
143
0.200
 Why?
Epoxide Hydrolases
1
2021
11
0.190
 Why?
Azabicyclo Compounds
1
2021
6
0.190
 Why?
Enzyme Activators
1
2021
7
0.190
 Why?
RNA, Messenger
3
2022
2732
0.190
 Why?
Benzoates
1
2021
40
0.190
 Why?
Dose-Response Relationship, Drug
2
2017
1983
0.190
 Why?
Endoscopy
4
2024
269
0.180
 Why?
Men's Health
1
2020
7
0.180
 Why?
Multicenter Studies as Topic
1
2022
290
0.180
 Why?
Infertility
1
2021
50
0.180
 Why?
Retrospective Studies
10
2024
14675
0.180
 Why?
Women's Rights
1
2020
3
0.170
 Why?
Disease Progression
5
2020
2639
0.170
 Why?
Communicable Disease Control
1
2020
72
0.170
 Why?
Virulence Factors
2
2014
153
0.170
 Why?
Aztreonam
2
2016
10
0.170
 Why?
Cataract
1
2022
197
0.170
 Why?
Colistin
1
2019
10
0.160
 Why?
Health Knowledge, Attitudes, Practice
2
2025
1272
0.160
 Why?
Neutrophils
3
2016
1209
0.160
 Why?
Follow-Up Studies
3
2024
4961
0.160
 Why?
Sexism
1
2020
54
0.160
 Why?
Contraception Behavior
1
2020
91
0.160
 Why?
Medication Therapy Management
1
2020
71
0.160
 Why?
Receptors, Interleukin-8B
1
2018
24
0.160
 Why?
Health Status
1
2023
756
0.150
 Why?
Contraception
1
2020
142
0.150
 Why?
Patient Reported Outcome Measures
1
2022
363
0.150
 Why?
Research Design
1
2024
1052
0.150
 Why?
Mental Health
1
2024
688
0.150
 Why?
Administration, Oral
1
2020
788
0.150
 Why?
Pyrimidines
1
2021
448
0.150
 Why?
Severity of Illness Index
5
2021
2785
0.140
 Why?
Cytochrome P-450 CYP3A Inducers
1
2017
5
0.140
 Why?
Pregnancy, High-Risk
1
2017
13
0.140
 Why?
HEK293 Cells
1
2020
686
0.140
 Why?
Longitudinal Studies
1
2024
2691
0.140
 Why?
Leukocytes
1
2018
303
0.140
 Why?
Risk Assessment
3
2021
3310
0.140
 Why?
Biological Availability
1
2017
131
0.140
 Why?
Respiratory Tract Infections
1
2021
373
0.130
 Why?
Research
1
2020
415
0.130
 Why?
Health Services Accessibility
2
2024
902
0.130
 Why?
Biphenyl Compounds
1
2017
63
0.130
 Why?
Risk Adjustment
1
2017
79
0.130
 Why?
Prognosis
2
2022
3830
0.130
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2019
217
0.130
 Why?
Attitude of Health Personnel
1
2023
1095
0.130
 Why?
Gene Expression Profiling
3
2018
1714
0.130
 Why?
Recovery of Function
1
2020
646
0.130
 Why?
Machine Learning
1
2020
433
0.120
 Why?
Albuterol
1
2016
105
0.120
 Why?
Pilot Projects
2
2020
1565
0.120
 Why?
Pharmacogenetics
1
2017
171
0.120
 Why?
Child, Preschool
3
2024
10514
0.120
 Why?
Adrenal Cortex Hormones
1
2018
527
0.120
 Why?
Interferons
1
2016
193
0.120
 Why?
Diabetes Complications
1
2016
228
0.120
 Why?
Cyclopropanes
2
2025
88
0.120
 Why?
Epithelial Cells
2
2020
1075
0.120
 Why?
Phosphodiesterase 5 Inhibitors
1
2014
37
0.120
 Why?
Metalloproteases
1
2014
43
0.110
 Why?
DNA Mutational Analysis
1
2015
395
0.110
 Why?
Staphylococcal Infections
1
2019
389
0.110
 Why?
Bronchodilator Agents
1
2016
252
0.110
 Why?
Genetic Predisposition to Disease
2
2015
2282
0.110
 Why?
Quorum Sensing
1
2014
73
0.110
 Why?
Body Mass Index
2
2023
2268
0.110
 Why?
Administration, Inhalation
3
2022
675
0.100
 Why?
Wound Infection
1
2013
32
0.100
 Why?
Neutrophil Activation
1
2013
79
0.100
 Why?
Mycobacterium Infections
1
2013
62
0.100
 Why?
Cellular Structures
1
2011
4
0.100
 Why?
Comorbidity
1
2016
1555
0.090
 Why?
Mycobacterium
1
2013
111
0.090
 Why?
Blood Glucose Self-Monitoring
1
2016
600
0.090
 Why?
Microbial Viability
1
2011
83
0.090
 Why?
Extracellular Space
1
2011
124
0.090
 Why?
Drug Therapy, Combination
3
2021
1028
0.090
 Why?
Patient Admission
1
2012
186
0.090
 Why?
Risk Factors
3
2020
9865
0.090
 Why?
Infant
1
2024
9049
0.090
 Why?
Leukocytes, Mononuclear
1
2013
550
0.090
 Why?
Survival Rate
2
2018
1904
0.080
 Why?
Aged
5
2024
22282
0.080
 Why?
Mass Screening
1
2016
1139
0.080
 Why?
Blood Group Antigens
1
2009
16
0.080
 Why?
Cardiovascular Diseases
1
2021
2028
0.080
 Why?
Burns
1
2013
289
0.080
 Why?
Inflammation
2
2022
2721
0.080
 Why?
Mucus
1
2009
75
0.070
 Why?
Inpatients
1
2012
462
0.070
 Why?
ADP Ribose Transferases
1
2007
8
0.070
 Why?
Exotoxins
1
2007
15
0.070
 Why?
Furin
1
2007
13
0.070
 Why?
Sexual Behavior
2
2022
455
0.070
 Why?
Oxygen Inhalation Therapy
1
2009
146
0.070
 Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2007
17
0.070
 Why?
Time Factors
3
2024
6615
0.070
 Why?
Cyclic GMP
1
2007
86
0.070
 Why?
Bacterial Toxins
1
2007
107
0.070
 Why?
Gene Expression Regulation
1
2016
2549
0.070
 Why?
Phenotype
1
2015
3084
0.070
 Why?
Registries
3
2023
1934
0.070
 Why?
Sulfones
1
2007
109
0.070
 Why?
Survivors
1
2010
463
0.070
 Why?
Respiratory System
1
2007
154
0.060
 Why?
Piperazines
1
2007
334
0.060
 Why?
Respiratory Mucosa
1
2007
314
0.060
 Why?
Respiration, Artificial
1
2009
600
0.060
 Why?
European Union
1
2024
10
0.060
 Why?
Reproductive Health Services
1
2023
14
0.050
 Why?
Logistic Models
2
2019
1980
0.050
 Why?
Standard of Care
1
2024
72
0.050
 Why?
Nose
1
2023
66
0.050
 Why?
United States Food and Drug Administration
1
2024
205
0.050
 Why?
Anemia, Iron-Deficiency
1
2024
58
0.050
 Why?
Cell Separation
2
2016
317
0.050
 Why?
Deoxyribonuclease I
1
2022
37
0.050
 Why?
Saline Solution, Hypertonic
1
2022
40
0.050
 Why?
Rare Diseases
1
2023
103
0.050
 Why?
Sex Education
1
2022
28
0.050
 Why?
Hot Flashes
1
2023
81
0.050
 Why?
Social Class
1
2024
258
0.050
 Why?
Contraceptive Agents
1
2022
60
0.050
 Why?
Iron
1
2024
287
0.050
 Why?
Health Status Disparities
1
2024
247
0.050
 Why?
Microbial Sensitivity Tests
2
2014
351
0.050
 Why?
Social Determinants of Health
1
2024
218
0.050
 Why?
Polymorphism, Single Nucleotide
1
2009
2074
0.050
 Why?
Biofilms
2
2014
248
0.050
 Why?
Nutritional Status
1
2023
328
0.050
 Why?
Preconception Care
1
2021
39
0.050
 Why?
Genetic Counseling
1
2021
72
0.040
 Why?
Attitude
1
2022
248
0.040
 Why?
Societies, Medical
1
2024
768
0.040
 Why?
Longevity
1
2021
151
0.040
 Why?
Contraceptives, Oral, Hormonal
1
2020
30
0.040
 Why?
Ambulatory Care
1
2023
511
0.040
 Why?
Menopause
1
2023
303
0.040
 Why?
Condoms
1
2020
102
0.040
 Why?
Tetraspanin 30
1
2018
10
0.040
 Why?
Sequence Analysis, DNA
1
2022
780
0.040
 Why?
Administration, Intravenous
1
2019
140
0.040
 Why?
British Columbia
1
2018
14
0.040
 Why?
Genetic Testing
1
2021
430
0.040
 Why?
Sex Factors
1
2024
1965
0.040
 Why?
Healthcare Disparities
1
2024
580
0.040
 Why?
Ecosystem
1
2023
562
0.040
 Why?
Diabetes Mellitus, Type 2
1
2012
2440
0.040
 Why?
Case-Control Studies
2
2016
3369
0.040
 Why?
trans-Golgi Network
2
2007
13
0.040
 Why?
Morbidity
1
2018
302
0.030
 Why?
Gene Deletion
1
2018
377
0.030
 Why?
Nitric Oxide Synthase Type II
2
2007
173
0.030
 Why?
Drug Administration Routes
1
2016
39
0.030
 Why?
Cells, Cultured
2
2018
4106
0.030
 Why?
Genetic Variation
1
2021
939
0.030
 Why?
Leadership
1
2020
358
0.030
 Why?
Interferon-alpha
1
2016
194
0.030
 Why?
Depression
1
2024
1298
0.030
 Why?
Practice Patterns, Physicians'
1
2023
1294
0.030
 Why?
Colorado
2
2018
4471
0.030
 Why?
Drug Resistance, Multiple, Bacterial
1
2014
71
0.030
 Why?
Cross-Sectional Studies
1
2025
5083
0.030
 Why?
Kaplan-Meier Estimate
1
2016
869
0.030
 Why?
Rats
1
2022
5285
0.030
 Why?
Medication Adherence
1
2018
577
0.030
 Why?
Odds Ratio
1
2016
1027
0.030
 Why?
Cohort Studies
1
2023
5431
0.030
 Why?
Survival Analysis
1
2016
1293
0.030
 Why?
Ciprofloxacin
1
2013
30
0.030
 Why?
Multivariate Analysis
1
2016
1510
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2013
328
0.020
 Why?
Superoxides
1
2013
201
0.020
 Why?
Drug Synergism
1
2013
361
0.020
 Why?
Suspensions
1
2011
34
0.020
 Why?
Cell Line
2
2007
2786
0.020
 Why?
Enteral Nutrition
1
2012
187
0.020
 Why?
Cell Adhesion
1
2011
454
0.020
 Why?
Age Distribution
1
2010
379
0.020
 Why?
Sex Distribution
1
2010
361
0.020
 Why?
Aged, 80 and over
1
2021
7128
0.020
 Why?
Insulin Infusion Systems
1
2012
362
0.020
 Why?
Age of Onset
1
2010
499
0.020
 Why?
Predictive Value of Tests
1
2013
1974
0.020
 Why?
Feedback, Physiological
1
2007
75
0.020
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2007
22
0.020
 Why?
Epithelial Sodium Channels
1
2007
18
0.020
 Why?
Guanylate Cyclase
1
2007
33
0.020
 Why?
Sodium
1
2007
208
0.020
 Why?
Purines
1
2007
170
0.020
 Why?
Hydrogen-Ion Concentration
1
2007
549
0.020
 Why?
In Vitro Techniques
1
2007
1067
0.020
 Why?
Transforming Growth Factor beta
1
2007
465
0.010
 Why?
Patient Acceptance of Health Care
1
2010
771
0.010
 Why?
Hypoglycemic Agents
1
2012
1218
0.010
 Why?
Mice
2
2013
16832
0.010
 Why?
Disease Models, Animal
1
2013
4044
0.010
 Why?
Mice, Transgenic
1
2007
2107
0.010
 Why?
Insulin
1
2012
2322
0.010
 Why?
Nitric Oxide
1
2007
896
0.010
 Why?
Macrophages
1
2007
1482
0.010
 Why?
Signal Transduction
1
2007
4930
0.010
 Why?
Taylor-Cousar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (30) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)